Gemtuzumab and disease progression Patient Reports February 13, 2012

Gemtuzumab Side Effects Report #5023836-5
Gemtuzumab side effect was reported by a Health Professional from FRANCE on May 30, 2006. Male patient, 38 years of age, was diagnosed with myeloid leukaemia and was treated with Gemtuzumab. After drug was administered, patient experienced the following side effects: blast cells present, disease progression, haemoglobin decreased, interstitial lung disease, leukocytosis, leukostasis, malignant neoplasm progression, myeloid leukaemia. Gemtuzumab dosage: 5 MG 1X PER 1 DAY INTRAVENOUS; SEE IMAGE. During the same period patient was treated with GEMTUZUMAB OZOGAMICIN, GEMTUZUMAB OZOGAMICIN, HYDREA, FLUCONAZOLE, FANSIDAR, ZOVIRAX, BACTRIM. Patient was hospitalized. Patient died.

Gemtuzumab Side Effects Report #5210315-5
Gemtuzumab side effect was reported by a Consumer or non-health professional from ITALY on Jan 05, 2007. Male patient, 83 years of age, was diagnosed with acute myeloid leukaemia and was treated with Gemtuzumab. After drug was administered, patient experienced the following side effects: blood lactate dehydrogenase increased, colitis ischaemic, disease progression, infection , intestinal haemorrhage, respiratory distress. Gemtuzumab dosage: 5 MG; SEE IMAGE. During the same period patient was treated with GEMTUZUMAB OZOGAMICIN, GLAZIDIM, TRIDECANAMINE, LEVOFLOXACIN, VORICONAZOLE, MEROPENEM, CYTARABINE. Patient died.

Gemtuzumab Side Effects Report #5019632-5
Gemtuzumab side effect was reported by a Consumer or non-health professional from ITALY on May 20, 2006. Male patient, 71 years of age, was diagnosed with acute myeloid leukaemia and was treated with Gemtuzumab. After drug was administered, patient experienced the following side effects: aplasia, aspergillosis, bone marrow disorder, disease progression, fungal infection , lung infiltration, mouth haemorrhage, oral fungal infection, skin necrosis. Gemtuzumab dosage: 10 MG 1X PER 1 DAY INTRAVENOUS. During the same period patient was treated with CYTARABINE, ETOPOSIDE, NOVANTRONE, AMPHOTERICIN B. Patient died.

Gemtuzumab Side Effects Report #4867726-7
Gemtuzumab side effect was reported by a Physician from UNITED STATES on Apr 13, 2002. Female patient, 68 years of age, was diagnosed with acute myeloid leukaemia and was treated with Gemtuzumab. After drug was administered, patient experienced the following side effects: anaemia, atelectasis, back pain , bacterial sepsis, disease progression, granulocytopenia, hyponatraemia, neutropenia, oedema peripheral. Gemtuzumab dosage: unknown. Patient died on 07/27/1998.


Gemtuzumab Side Effects Report #5293573-0
Gemtuzumab side effect was reported by a Physician from FRANCE on Apr 06, 2007. Male patient, 49 years of age, was diagnosed with acute myeloid leukaemia and was treated with Gemtuzumab. After drug was administered, patient experienced the following side effects: disease progression, multi-organ failure, venoocclusive liver disease. Gemtuzumab dosage: unknown. During the same period patient was treated with ACYCLOVIR, VANCOMYCIN, FLUDARABINE PHOSPHATE, IDARUBICIN, INIPOMP, CONTRAMAL, CIPROFLOXACIN, ZOPHREN. Patient died on 03/03/2007.

Gemtuzumab Side Effects Report #4867129-5
Gemtuzumab side effect was reported by a Health Professional from FRANCE on Mar 10, 2002. Female patient, 46 years of age, was diagnosed with acute myeloid leukaemia and was treated with Gemtuzumab. After drug was administered, patient experienced the following side effects: acute myeloid leukaemia, disease progression, haemorrhage, menometrorrhagia, neutropenia, thrombocytopenia. Gemtuzumab dosage: 9 MG/M (2) INTRAVENOUS. During the same period patient was treated with GEMTUZUMAB OZOGAMICIN. Patient was hospitalized. Patient died.

Gemtuzumab Side Effects Report #4970760-X
Gemtuzumab side effect was reported by a Consumer or non-health professional from NETHERLANDS on Mar 28, 2006. Male patient, 14 years of age, was diagnosed with acute myeloid leukaemia and was treated with Gemtuzumab. After drug was administered, patient experienced the following side effects: blood pressure decreased, disease progression. Gemtuzumab dosage: unknown. Patient died.

Gemtuzumab Side Effects Report #4974410-8
Gemtuzumab side effect was reported by a Physician from NETHERLANDS on Mar 28, 2006. Male patient, 14 years of age, was diagnosed with acute myeloid leukaemia and was treated with Gemtuzumab. After drug was administered, patient experienced the following side effects: blood pressure decreased, disease progression. Gemtuzumab dosage: unknown. Patient died.

Gemtuzumab Side Effects Report #5288624-3
Gemtuzumab side effect was reported by a Physician from ITALY on Mar 30, 2007. Male patient, weighting 136.7 lb, was diagnosed with acute myeloid leukaemia and was treated with Gemtuzumab. After drug was administered, patient experienced the following side effects: colitis ischaemic, disease progression, infection , respiratory distress. Gemtuzumab dosage: unknown. During the same period patient was treated with GEMTUZUMAB OZOGAMICIN, MEROPENEM, LEVOFLOXACIN, VORICONAZOLE, GLAZIDIM, TRIDECANAMINE. Patient died on 12/05/2006.


Gemtuzumab Side Effects Report #5363276-2
Gemtuzumab side effect was reported by a Physician from ITALY on June 11, 2007. Male patient, weighting 136.7 lb, was diagnosed with acute myeloid leukaemia and was treated with Gemtuzumab. After drug was administered, patient experienced the following side effects: colitis ischaemic, disease progression, intestinal haemorrhage, pneumonia . Gemtuzumab dosage: ACTUAL DOSE 5 MG; CUMMULATIVE DOSE 15 MG. During the same period patient was treated with MEROPENEM, LEVOFLOXACIN, VORICONAZOLE, GLAZIDIM, TRIDECANAMINE. Patient died on 12/05/2006.

Gemtuzumab Side Effects Report #5520559-0
Gemtuzumab side effect was reported by a Physician from ITALY on Nov 14, 2007. Male patient, weighting 136.7 lb, was diagnosed with acute myeloid leukaemia and was treated with Gemtuzumab. After drug was administered, patient experienced the following side effects: colitis ischaemic, disease progression, intestinal haemorrhage, pneumonia , respiratory distress. Gemtuzumab dosage: ACTUAL DOSE 5 MG; CUMMULATIVE DOSE 15 MG. During the same period patient was treated with MEROPENEM, LEVOFLOXACIN, VORICONAZOLE, GLAZIDIM, TRIDECANAMINE. Patient died on 12/05/2006.

Gemtuzumab Side Effects Report #6084935-2
Gemtuzumab side effect was reported by a Physician from FRANCE on Feb 13, 2009. Female patient, weighting 132.3 lb, was diagnosed with acute myeloid leukaemia and was treated with Gemtuzumab. After drug was administered, patient experienced the following side effects: cerebral haematoma, cerebral haemorrhage, disease progression, thrombocytopenia, treatment failure. Gemtuzumab dosage: 5 MG TOTAL DAILY. Patient was hospitalized. Patient died on 02/10/2009.

Gemtuzumab Side Effects Report #6086130-X
Gemtuzumab side effect was reported by a Physician from FRANCE on Feb 13, 2009. Female patient, weighting 132.3 lb, was diagnosed with acute myeloid leukaemia and was treated with Gemtuzumab. After drug was administered, patient experienced the following side effects: cerebral haematoma, cerebral haemorrhage, disease progression, thrombocytopenia. Gemtuzumab dosage: 5 MG TOTAL DAILY. Patient was hospitalized. Patient died on 02/10/2009.

Gemtuzumab Side Effects Report #6099042-2
Gemtuzumab side effect was reported by a Physician from FRANCE on Feb 23, 2009. Female patient, weighting 132.3 lb, was diagnosed with acute myeloid leukaemia and was treated with Gemtuzumab. After drug was administered, patient experienced the following side effects: cerebral haematoma, cerebral haemorrhage, disease progression, thrombocytopenia. Gemtuzumab dosage: 5 MG TOTAL DAILY. During the same period patient was treated with CYTARABINE, DAUNORUBICIN. Patient was hospitalized. Patient died on 02/10/2009.